Altec Medico IVS
Credit rating
Company information
About Altec Medico IVS
Altec Medico IVS (CVR number: 38531476) is a company from RUDERSDAL. The company reported a net sales of 0.6 mDKK in 2020, demonstrating a growth of 87.7 % compared to the previous year. The operating profit percentage was at 21.8 % (EBIT: 0.1 mDKK), while net earnings were 119.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 38.4 %, which can be considered excellent and Return on Equity (ROE) was 47 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 66.7 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Altec Medico IVS's liquidity measured by quick ratio was 5.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|
Volume | ||||
Net sales | 298.55 | 474.08 | 339.60 | 637.37 |
Gross profit | 182.21 | 319.85 | 232.37 | 211.79 |
EBIT | 182.21 | 235.15 | 106.93 | 139.20 |
Net earnings | 38.79 | 107.26 | 119.85 | |
Shareholders equity total | 74.01 | 112.16 | 194.86 | 314.74 |
Balance sheet total (assets) | 146.24 | 170.07 | 253.51 | 471.80 |
Net debt | -12.29 | -96.80 | - 161.13 | -59.96 |
Profitability | ||||
EBIT-% | 61.0 % | 49.6 % | 31.5 % | 21.8 % |
ROA | 124.6 % | 148.7 % | 51.4 % | 38.4 % |
ROE | 41.7 % | 69.9 % | 47.0 % | |
ROI | 164.4 % | 183.2 % | 54.5 % | 43.6 % |
Economic value added (EVA) | 129.37 | 233.90 | 107.85 | 122.96 |
Solvency | ||||
Equity ratio | 50.6 % | 66.0 % | 76.8 % | 66.7 % |
Gearing | 49.8 % | 30.0 % | 30.1 % | |
Relative net indebtedness % | 7.7 % | -15.3 % | -47.4 % | 4.3 % |
Liquidity | ||||
Quick ratio | 2.8 | 2.9 | 5.3 | |
Current ratio | 2.8 | 2.9 | 5.3 | |
Cash and cash equivalents | 49.14 | 130.47 | 219.77 | 59.96 |
Capital use efficiency | ||||
Trade debtors turnover (days) | 118.7 | 18.2 | 83.6 | 6.0 |
Net working capital % | 31.8 % | 23.7 % | 27.1 % | 58.6 % |
Credit risk | ||||
Credit rating | B | B | B | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.